One-Two Punch: Vaccine fights herpes with antibodies, T cells | Science News

SUPPORT SCIENCE NEWS

Help us keep you informed.

Real Science. Real News.


News

One-Two Punch: Vaccine fights herpes with antibodies, T cells

By
12:00pm, December 21, 2004

An experimental vaccine tested in animals incites a double-edged immune reaction against the virus that causes genital herpes. The finding may pave the way for tests in people. The vaccine stirred up both antibodies and immune cells against herpes simplex virus 2, suggesting it might work as both a preventive and a treatment. Herpes causes painful skin blisters and spreads easily from person to person.

Other herpes vaccines created from viral proteins (SN: 12/21/02, p. 399: Available to subscribers at Herpes vaccine progresses) and viral DNA (SN: 8/19/00, p. 116: Available to subscribers at DNA vaccine immunizes fetal lambs) have induced antibody production against the virus but delivered inconsistent benefits. The new vaccine, called dl5-29 and made by Avant Immunotherapeutics of Needham, Mass., instead consists of a live herpes virus that's missing two critical genes. Another potential vaccine, further along in testing, is m

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content